Analysis focused on two previously published datasets (8, 9), both generated from an in vivo experiment in which the Lewis lung (3LL) carcinoma model was treated with the KRAS-G12C inhibitor MRTX1257 or vehicle for 7 days before harvesting of the lungs. The gene discussed is KRAS; the disease is carcinoma.